PIN54 COST-EFFECTIVENESS ANALYSES (CEA) OF LOPINAVIR/RITONAVIR (LPV/R) AND ATAZANAVIR PLUS RITONAVIR (ATV VE HIV-1 INFECTED PATIENTS BASED ON CASTLE 48-WEEK STUDY- APPLICATION TO SWEDEN
Abstract
Authors
K Simpson R Baran C Woodward B Dietz